Herman, Jonathan D. http://orcid.org/0000-0001-7188-4243
Wang, Chuangqi
Loos, Carolin
Yoon, Hyunah http://orcid.org/0000-0001-5050-6876
Rivera, Johanna
Eugenia Dieterle, M. http://orcid.org/0000-0002-5257-7253
Haslwanter, Denise
Jangra, Rohit K.
Bortz, Robert H. III
Bar, Katharine J.
Julg, Boris http://orcid.org/0000-0002-4687-9626
Chandran, Kartik http://orcid.org/0000-0003-0232-7077
Lauffenburger, Douglas http://orcid.org/0000-0002-0050-989X
Pirofski, Liise-anne
Alter, Galit http://orcid.org/0000-0002-7680-9215
Funding for this research was provided by:
Bill and Melinda Gates Foundation
Article History
Received: 8 March 2021
Accepted: 28 October 2021
First Online: 25 November 2021
Competing interests
: G.A. is a founder of SeromYx Systems, Inc. and an equity holder in Leyden Labs. G.A. is a member of the scientific advisory board of Sanofi Pasteur. K.C. is a member of the scientific advisory boards of Integrum Scientific LLC, Biovaxys Technology Corp, and the Pandemic Security Initiative of Celdara Medical, LLC. K.C., M.E.D., D.H., and R.K.J., are named co-inventors on a patent application assigned to Albert Einstein College of Medicine that covers a SARS-CoV-2 surrogate neutralization assay. The remaining authors declare no competing interests.